α2-Adrenergic Agonists or Stimulants for Preschool-Age Children With Attention-Deficit/Hyperactivity Disorder.
| Author | |
|---|---|
| Abstract |
:
Attention-deficit/hyperactivity disorder (ADHD) is diagnosed in approximately 2.4% of preschool-age children. Stimulants are recommended as first-line medication treatment. However, up to 25% of preschool-age children with ADHD are treated with α2-adrenergic agonist medications, despite minimal evidence about their efficacy or adverse effects in this age range. |
| Year of Publication |
:
2021
|
| Journal |
:
JAMA
|
| Volume |
:
325
|
| Issue |
:
20
|
| Number of Pages |
:
2067-2075
|
| Date Published |
:
2021
|
| ISSN Number |
:
0098-7484
|
| URL |
:
https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.6118
|
| DOI |
:
10.1001/jama.2021.6118
|
| Short Title |
:
JAMA
|
| Download citation |
